In addition to their role in treating diabetes, several studies have evaluated the potential of DPP-4 inhibitors as immune-modulating agents and as a treatment for chronic allograft dysfunction following lung transplantation (11, 15). The gene discussed is DPP4; the disease is diabetes mellitus.